SNM 2008 Preview

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

June 14-18 | New Orleans


Nearly 4,000 physicians, scientists, pharmacists and technologists are expected to meet in New Orleans this month from June 14-18 when the Society of Nuclear Medicine (SNM) convenes its 55th Annual Meeting at the Ernest N. Morial Convention Center. More than 1,600 scientific, technologist and technologist-student abstracts are being presented featuring the latest research in molecular imaging and nuclear medicine.

New featured events include the Joint SNM/U.S. Pharmacopoeia Symposium on June 14, 8 a.m.–4 p.m., an NCI Workshop on the Use of PET/CT in the Clinic and Clinical Trials on June 14, 8 a.m.–4 p.m., and the on-going Novel Approaches to Molecular Imaging.

Capintec (Booth 1355) is unveiling two new products—Captus 3000 Emergency Population Screening System (EPSS) and CapIMAGE Small Field of View Gamma Camera System.

CapIMAGE, designed for imaging small organs and body parts including the thyroid, parathyroid, extremities and gated cardiac studies, has a small footprint with a detector. The system provides detailed images with rapid acquisition, processing and data storage via DICOM connectivity.

The Captus 3000 EPSS combines Capintec’s Captus 3000 Thyroid Uptake system with software designed for emergency population screening and quantification of internal organ contamination associated with a radiologic event. The light, portable stand folds for transport. The Captus 3000 protocol module allows users to develop customized measurement and calculation protocols.

DMS Imaging Interim Solutions (Booth 871) is showcasing PET/CT systems at reduced rates, producing a limited quantity of mobile GE Discovery ST8 and Siemens Biograph PET/CT systems.

DMS provides support services, including temporary staffing, applications training, business development and marketing, scheduling and FDG at national contract pricing.

GE Healthcare (Booth 427) is highlighting several new systems in SPECT/CT, pre-clinical imaging, PET/CT as well as radiopharmaceuticals.

In SPECT/CT, GE is featuring its new Volumetrix Suite, consisting of two software packages—Volumetrix 3D and Volumetrix IR. The Volumetrix 3D brings together advanced 3D visualization with the productivity of 2D image analysis. Volumetrix IR offers a clinician the choice of CT to register with the SPECT data within the nuclear medicine workflow.

For pre-clinical imaging, GE is showing its new eXplore speCZT, a full-ring, solid-state detector small animal SPECT that utilizes a cadmium zinc telluride (CZT) detector, and allows for 360-degree coverage around the animal and high-energy resolution to enable dual or triple radio-nuclide imaging.

For PET/CT, the company is showcasing its Discovery Dimension that allows the clinician to address the PET and CT imaging mismatches related to respiratory and cardiac motion, which include motion correction techniques. GE provides technologies for its Discovery—high-definition PET image processing, patient motion management and clinical productivity features—that address motion.

For radiopharmaceuticals, GE is featuring its FASTlab, a multi-tracer PET chemistry synthesis platform that features a cassette to incorporate pre-measured, pre-loaded reagents.

IBA Molecular (Booth 1034) is presenting its IntegraLab solution and Cyclone 18 Twin.

IntegraLab combines products and services for the production of radiopharmaceuticals, including among others, building design according to cGMP and the selection, integration, supply and installation of equipment to match customer’s radioisotope production goals.

The Cyclone 18 Twin is a new version of IBA’s Cyclone 18/9, which increases production uptime while reducing maintenance intervention. The Cyclone 18 Twin central region also has been redesigned to host two new proton ion sources, aiding the other features of Cyclone 18 family.

Lantheus Medical Imaging (Booth 1425) is highlighting Cardiolite, the technetium-labeled myocardial perfusion agent that has been used to image more than 40 million patients to date.  

From its pipeline, Lantheus is featuring its initiative through clinical data presented on and F-labeled PET tracer (BMS-747158), a new PET agent. 

Medrad (Booth 225) is featuring its Intego PET Infusion System, a technology designed for CT, MRI and which continues with the injector technology for molecular imaging. The Intego allows for dose-on-demand capability for flexible exam scheduling; automated and controlled delivery with built-in